Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial - Wikidata - wikimedia - TriplyDB

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

http://www.wikidata.org/entity/Q34336573

about

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia The search for novel analgesics: targets and mechanisms Chemotherapy-induced peripheral neuropathy: an update on the current understanding American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline American Cancer Society Colorectal Cancer Survivorship Care Guidelines Chemotherapy-induced peripheral neurotoxicity: a critical analysis Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells Vincristine-induced peripheral neuropathy in pediatric cancer patients Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology Chemotherapy-induced neuropathies-a growing problem for patients and health care providers An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US.Optimizing adjuvant therapy and survivorship care of stage III colon cancer.Symptom management in the older adult: 2015 update A phase 2 study of fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as a salvage treatment in patients with refractory or relapsed advanced gastric cancer.Efficacy and tolerability of controlled-release oxycodone for oxaliplatin-induced peripheral neuropathy and the extension of FOLFOX therapy in advanced colorectal cancer patients.Pain in cancer survivors A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy.North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancer.Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study Brain activity changes in a macaque model of oxaliplatin-induced neuropathic cold hypersensitivity.Review of a study of duloxetine for painful chemotherapy-induced peripheral neuropathy.A simple ratio-based approach for power and sample size determination for 2-group comparison using Rasch models.Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.Therapeutic strategies for cancer treatment related peripheral neuropathies.Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer.Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review.A trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy.Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy Platinum-induced neurotoxicity and preventive strategies: past, present, and future Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction.Survivorship: pain version 1.2014 Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.

P2860

Q24201220-4EAB0934-8157-4034-9DD2-642360CE13B9 Q24288817-A7283E92-5082-4EA0-AD1C-B52090905735 Q26740689-FEB73899-68A4-429C-9CEC-88A8824E1660 Q26773986-48648A30-7330-4CC6-9D27-2EBA5EA22D44 Q26782671-C852984C-669E-4D11-ACD3-04465E666F79 Q27010318-2EDAC45F-C7B2-4EC1-96DC-10BA2BEE27EA Q27305830-84FEA285-A976-4623-B7D0-2E696F2E6617 Q27314983-957F526C-4553-408D-B282-692E5DF21637 Q28078232-45CAFD3B-5972-43B3-A06B-6347B16C3E5B Q28270819-24B3926A-E0EE-49DE-8449-EDF7CB24209B Q28551798-09863DCB-A432-420E-ADB6-4B7CD42FAB62 Q28818565-B004A12D-3907-4C84-A460-EBBD2F34BB8F Q30236003-3E33287A-791A-477A-B2FA-DE90DF0CE261 Q30249616-F1093590-D549-487D-B942-B9CBEBA492C8 Q30374202-1F9FFC26-98DF-4BFD-B601-5454F31DAE56 Q33416115-22A16F46-4E62-4AFA-97C4-1CB594139E74 Q33561260-8DC12318-0B17-48BB-BAF1-1F8DD18081D0 Q33650576-113E485E-2D4B-41E0-B64D-4DB4FD7C59D8 Q33693343-3DA40F99-FF1A-44D9-BAAB-B63BFE3F664E Q33711666-9ECEB2ED-FD11-4303-8390-EDE4FCCECCC4 Q33717608-8A087302-926E-411E-BA3A-201A51BB5F73 Q33744706-C1B0E62C-1D3C-469B-B98C-04484A16740F Q33777302-7E040B9C-795C-4FFE-97D3-18852FABD812 Q33796889-09B7D48A-9270-41B7-9E27-5AA690A62CC3 Q33842874-D14A3837-0C12-4850-AA04-E431EB42E168 Q33886065-492C4FD3-133D-499C-A71B-E746842FA163 Q33929392-777442BF-0EDA-4468-96ED-359F4392EDD4 Q33984071-D45C4E3E-DD12-41EB-87EC-2DDF62C6AD4A Q34433406-3012AEB9-6870-4612-BDEA-902D2460C180 Q34458581-63A505F9-F95D-4496-B257-457FDA9B6B3A Q34756198-524A9E8D-A3C2-4630-B530-C74C0F3256BB Q35002187-383A6846-0D86-4A90-9A2B-06A01CFD7078 Q35143365-1C9BD4D2-F7E5-48A9-9955-E9E9D28D31E3 Q35230341-FDBDC9E5-F630-442A-8DA1-8BF0E0F77FC1 Q35248891-64922B77-5553-471B-AFD7-32B45BF6D0ED Q35345734-22E32359-03BD-4473-A934-1533B92F7497 Q35596252-548163B2-502E-432A-92DA-7603C1C16544 Q35686543-1978F316-5357-4F1C-A2FA-5A84A44604C1 Q35734956-E815775E-CA84-4584-AD91-E22186406760 Q36057728-7E91FAFD-59C5-415D-9419-DC661F931650

P2860

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

http://www.wikidata.org/entity/Q34336573

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Effect of duloxetine on pain, ...... y: a randomized clinical trial

@ast

Effect of duloxetine on pain, ...... y: a randomized clinical trial

@en

Effect of duloxetine on pain, ...... y: a randomized clinical trial

@nl

type

label

Effect of duloxetine on pain, ...... y: a randomized clinical trial

@ast

Effect of duloxetine on pain, ...... y: a randomized clinical trial

@en

Effect of duloxetine on pain, ...... y: a randomized clinical trial

@nl

prefLabel

Effect of duloxetine on pain, ...... y: a randomized clinical trial

@ast

Effect of duloxetine on pain, ...... y: a randomized clinical trial

@en

Effect of duloxetine on pain, ...... y: a randomized clinical trial

@nl

P1433

Q34336573-DBAD6EEE-8E6C-4F40-8895-337149CCF7A1

P1476

Q34336573-0838E2BD-EF0C-4D08-B065-4023FC00CF8F

P2093

Q34336573-0C47F48F-0879-49E8-83CB-95C5F8AB122B

Q34336573-0C7EE5E9-B721-48A4-9D7D-CD5E18B8D488

Q34336573-184491D0-A4C9-4811-AC1A-73B0F4B38869

Q34336573-423A91FF-740D-42AE-AD60-67F0CDCECAB4

Q34336573-423ADDD0-FD2F-4CA1-8670-57CF3E4EA025

Q34336573-49A666DA-B2C3-4457-AE26-8D813A271D8E

Q34336573-6E2A0F6F-BC53-4BF5-97F1-4AA5BF9FE922

Q34336573-90FD4FC4-F5FA-4324-9DCE-3A057C3B2F2E

Q34336573-A211E53C-0583-40E9-BB57-9531B6C74410

Q34336573-B2B3DA5B-06F4-48F6-A205-79F016C4A399

P2860

Q34336573-01069BCE-9CC4-4735-AF5F-EA73C23FADC1

Q34336573-02466C28-F7C1-4ED0-8377-48E0A2AB774A

Q34336573-05FE4B7B-4433-4954-923B-07429BC782C6

Q34336573-0773429A-DAF3-4CBF-B7CE-65E5E8CA6A98

Q34336573-1B4E7A54-C55E-4D76-9925-91DBB529FE5B

Q34336573-21336D4F-1FF6-4BCA-B3D3-F592BA3D6E60

Q34336573-22351943-1CE2-4B18-882A-ABF1AA7A2E2C

Q34336573-25953C55-91BC-40FE-99D4-42AADBF1A5EF

Q34336573-28C2D84A-5AC4-4B7F-B5DA-7622FB368B40

Q34336573-29614FFD-32F5-40A4-AF54-4F4B8404231F

P304

Q34336573-C0277062-5B8B-4492-A2C6-1BCBBB74ABCB

P31

Q34336573-1D5BFB95-C2EF-44BC-8134-76A7E142E2A9

P356

Q34336573-8E997D01-A7DC-4CC4-851D-10B989555722

P407

Q34336573-1037E807-3E39-471B-8F6A-1878D9C78CB9

P433

Q34336573-2D7735A7-2EE8-481F-8F45-DAACBA3F6FFF

P478

Q34336573-53279E9C-2BC5-419C-8699-A969526C918C

P577

Q34336573-A14CF6C0-3901-4F4B-9519-E24E24C816C1

P698

Q34336573-C1F81755-D11C-47F0-AC41-BCC48B9D5973

P921

Q34336573-4F31600F-BDFC-4932-BF56-644E1930D9A2

Q34336573-509F0CE0-18CB-4626-8FDE-6795D04EBEAD

Q34336573-BE18E8C0-4582-4BDA-AAFA-29BB35A1208A

P932

Q34336573-4DA3AD48-3646-4EB3-BFEE-65E1405563E1

P356

P1433

Journal of the American Medical Association

P1476

Effect of duloxetine on pain, ...... y: a randomized clinical trial

@en

P2093

Alliance for Clinical Trials in Oncology

http://www.w3.org/2001/XMLSchema#string

Camilo E Fadul

http://www.w3.org/2001/XMLSchema#string

Charles L Shapiro

http://www.w3.org/2001/XMLSchema#string

Chetaye Knox

http://www.w3.org/2001/XMLSchema#string

Constance Cirrincione

http://www.w3.org/2001/XMLSchema#string

Electra D Paskett

http://www.w3.org/2001/XMLSchema#string

Ellen M Lavoie Smith

http://www.w3.org/2001/XMLSchema#string

Herbert Pang

http://www.w3.org/2001/XMLSchema#string

Linda R Bressler

http://www.w3.org/2001/XMLSchema#string

Nguyet Le-Lindqwister

http://www.w3.org/2001/XMLSchema#string

P2860

Antidepressants for neuropathic pain

Pain assessment: global use of the Brief Pain Inventory

Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.

Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.

The effect of symptom clusters on functional status and quality of life in women with breast cancer

Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation

Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract.

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Diabetic neuropathy: clinical manifestations and current treatments.

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

P304

1359-1367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2013.2813

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

309

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23549581

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

3912515

http://www.w3.org/2001/XMLSchema#string